TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Tmax of ustekinumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of ustekinumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maxillary complete denture base retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of easy IUD insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Need for Rescue Medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Complete antipyretic time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse reaction (AR)
Endpoint domain: Adverse events/effects
Primary endpoint: Open-ended questions response quality
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual Analogue Scale (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time-to-actionable result
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Biomarkers of vascular injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Biomarkers of glycocalyx injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Serum and urine iodine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TNM staging of papillary thyroid cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and connective tissue outcomes
Primary endpoint: Seniors Technology Acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health Intervention Acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cardiac movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: skeletal muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: skeletal muscle movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Knowledge of Supporting Integrated dCBTi
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence rate of sacral stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of 'major LARS' in the patient cohort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of 'major LARS' symptoms in relation to surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of 'major LARS' symptoms in relation to radiotherapy treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity Questionnaire for Children (PAQ-C)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical Activity Questionnaire for Adolescent (PAQ-A)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of complete pathologic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 24-Hour Pad Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants indicating pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of intraocular lens implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intervention Adherence
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Heart Transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Rehospitalization for Heart Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CAB trough concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in anxiety/depression levels (HADS score)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in the patient's perception of overall health status (EQ-VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Daily food intake
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Identification rate of ICG-guided SN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total control of nausea and vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical Pregnancy Rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ongoing Pregnancy Rate (OPR)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Live Birth Rate (LBR)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement or resolution of signs and symptoms in UTIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost effectiveness of Unani formulations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Phlebitis Evaluation Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decompensation events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of isthmocele
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Maximum tolerated dose (MTD) of CS2009
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tentative recommended Phase II dose (RP2D) of CS2009
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective response rate (ORR) evaluated by investigators per RECIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of HIV-uninfected patients with laboratory-confirmed SARS-CoV-2 illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of patients with laboratory-confirmed SARS-CoV-2 illness who have been vaccinated with at least one dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 36-Item Short Form Survey Instrument (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: clinical response rate (CR+PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Taste Sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mitochondrial respiratory chain complex I activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate opacification of the myocardium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of treatment-related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of serious infections requiring medical assessment or hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Whole Blood Count (WBC) parameter equivalency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Red Blood Count (RBC) parameter equivalency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hemoglobin (HGB) parameter equivalency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Acceptability of the coaching programs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Actual usage of the coaching programs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety of the coaching programs
Endpoint domain: Adverse events/effects
Primary endpoint: HPV6 antibodies at 13 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HPV11 antibodies at 13 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HPV16 antibodies at 13 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HPV18 antibodies at 13 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HPV31 antibodies at 13 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HPV33 antibodies at 13 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in self-reported dietary intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monthly incidence of severe Group A Streptococcus infections
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor NIR Signal Compared to Background Brain Normal Signal (SBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIR Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIR True Positive Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jenkins Sleep Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Diaphragm movement after block performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in variability in number of steps to complete a turn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Daytime sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Seated interface pressure distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microenvironmental status I - temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microenvironmental status II - humidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Brain Derived Neurotropic Factor (BDNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum observed plasma concentration (Cmax) of Belantamab Mafodotin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Cmax (Tmax) of Belantamab Mafodotin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC) of Belantamab Mafodotin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of PHLF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required for fibroid fragmentation and retrieval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Risk Rate of Readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevalence of pertussis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Restoration Retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collateral status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemocompatibility Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical procedure impact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mullen Scales of Early Learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Success Susceptible Population
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily Score of 8 symptoms related to mucus production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of counseling appointment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Participation in planned training volume
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of emergency delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in emotional eating score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mother-to-Infant Bonding Scale (MIBS-J)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with clinically significant abnormal laboratory test results
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormal electrocardiogram readings: QTcF
Endpoint domain: Adverse events/effects
Primary endpoint: trunk inclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: pelvic inclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: lordotic angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: lumbar arrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: cervical arrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: pCR following neoadjuvant chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Segment-specific lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in the Childbirth Self-Efficacy Inventory (CBSEI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Edinburgh Depression Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Generalized Anxiety Disorder (GAD)-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Urges to act on sexual behaviors involving children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Vaginal Health Index (VHI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newborn Fat Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SMA margin status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: All-cause, 28-day, in-hospital mortality
Endpoint domain: Mortality/survival
Primary endpoint: Identify robust candidates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of fear related to colonoscopy
Endpoint domain: Adverse events/effects
Primary endpoint: Intent to complete a colonoscopy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in quality of life of autistic youth
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in transition-related goal attainment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in youth problem behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RAADS-R-DK
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptance of gynecological consultation
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in Visual Field Mean Deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in 5000 m run performance (time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cognitive performance #1 (score)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Cognitive performance #2 (score)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Feasibility and Tolerability Questionnaire (FTQ) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Lu AG09222 Serum Concentration-Time Curve (AUC) From Zero to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Lu AG09222
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Elimination Half-Life (t½) of Lu AG09222
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse outcome events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in ADHD-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Eyberg Child Behavior Inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Clinician Global Impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: renal morphology - fibroblasts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: renal morphology - inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: renal morphology - oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motivational form of apathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive form of apathy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Behavioural form of apathy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Catch-up growth degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean change in blood AEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diagnosis accuracy of ultrasound for acute abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FAAM-U
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative residual neuromuscular block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean daily post-operative physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mothers' stress levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mothers' satisfaction levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intraoperative injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Right-Left Discrimination Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral morphine equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of penicillin allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: biochemical recurrence-free rates
Endpoint domain: Mortality/survival
Primary endpoint: urinary control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Endothelial cell-derived microvesicles concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gugging Swallowing Screen (GUSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restenosis rate of the target lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change of static standing balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of functional reach test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination of CAD presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection of coronary inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Operationality and performance of the plugin
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of intraoperative visceral pain
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Mean Hb Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rebound pain VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of preventive care services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Healthcare Utilization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Parent Experiences of Care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Cognitive Change (Composite Score)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Detection rates of H. pylori infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in oxygen consumption rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ATPmax levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental health treatment initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from Baseline Student-Advocates Pre- and Post-Scale (SAPPS) at Immediate Post-Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Student-Advocates Pre- and Post-Scale (SAPPS) at 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing